No study locations reported - 01 Sep `25Dexamethasone with light therapy for vitiligo

Dexamethasone with light therapy for vitiligo

Official title: Expression of CXCL11 & TEMRA in Serum of Vitiligo Patients Treated With Narrow-band UVB

Status: Opening soon

Description:

Assiut University plans to enroll about 40 participants. The study uses controlled ultraviolet light, sometimes with an immune-modulating medicine. UV light can stimulate surviving melanocytes and may help affected skin regain color. Possible effects include redness, itching, dryness, sunburn-like reactions, and with repeated exposure, premature skin aging or a higher skin-cancer risk. The study record does not list an age range. Recruitment has not started, and no locations are listed yet.

Start date: September 01, 2025

Completion date: September 30, 2026

Organizer: Assiut University

Contact: See contacts and locations in the ClinicalTrials.gov record

Link: https://clinicaltrials.gov/study/NCT06946069

Clinical Trial Alerts

Sign up and be the first to know about updates on this trial.

This request will be sent with the trial reference Dexamethasone with light therapy for vitiligo . By submitting you agree to our Privacy Policy.

FAQOther Questions

  • Vitiligo trials for kids: basics for the parents

    Pediatric vitiligo trials · The basics Two parallel studies are evaluating investigational use of ruxolitinib cream in young children — researchers are still finding out how wel...

  • How Vitiligo Changes with Age?

    Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...

  • Vitiligo and hearing loss: any connection?

    Vitiligo is primarily recognized for causing skin discoloration, but it can also impact melanocytes in unexpected areas, such as the inner ear. This raises questions about wheth...